Please note that the copy function is not enabled for this field.
If you wish to
modify
existing outcomes, please copy and paste the current outcome text into the Update field.
LOGIN
CREATE ACCOUNT
LOGIN
CREATE ACCOUNT
MY TRIALS
REGISTER TRIAL
FAQs
HINTS AND TIPS
DEFINITIONS
Trial Review
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been endorsed by the ANZCTR. Before participating in a study, talk to your health care provider and refer to this
information for consumers
Download to PDF
Trial registered on ANZCTR
Registration number
ACTRN12605000077662
Ethics application status
Approved
Date submitted
25/07/2005
Date registered
5/08/2005
Date last updated
22/08/2007
Type of registration
Retrospectively registered
Titles & IDs
Public title
A non-randomised Phase III study to evaluate the effectiveness of Deflazacort in boys with Duchenne muscular dystrophy in improving muscle strength and function and minimising side effects.
Query!
Scientific title
A non-randomised Phase III study to evaluate the effectiveness of Deflazacort in boys with Duchenne muscular dystrophy in improving muscle strength and function and minimising side effects.
Query!
Universal Trial Number (UTN)
Query!
Trial acronym
Query!
Linked study record
Query!
Health condition
Health condition(s) or problem(s) studied:
Duchenne muscular dystrophy
152
0
Query!
Condition category
Condition code
Musculoskeletal
171
171
0
0
Query!
Other muscular and skeletal disorders
Query!
Intervention/exposure
Study type
Interventional
Query!
Description of intervention(s) / exposure
12-month trial of Deflazacort vs prednisone given as part of routine clinical care
Query!
Intervention code [1]
64
0
Treatment: Drugs
Query!
Comparator / control treatment
Query!
Control group
Active
Query!
Outcomes
Primary outcome [1]
210
0
Improvement in muscle strength
Query!
Assessment method [1]
210
0
Query!
Timepoint [1]
210
0
Measured prior to commencement on deflazacort, then 1, 3, 6, 9 and 12 months after starting the treatment.
Query!
Secondary outcome [1]
479
0
Minimum side effects (weight gain, behavioural changes).
Query!
Assessment method [1]
479
0
Query!
Timepoint [1]
479
0
Query!
Eligibility
Key inclusion criteria
Duchenne muscular dystrophy, walking independently, failed Prednisone.
Query!
Minimum age
4
Years
Query!
Query!
Maximum age
15
Years
Query!
Query!
Sex
Both males and females
Query!
Can healthy volunteers participate?
No
Query!
Key exclusion criteria
No exclusion criteria
Query!
Study design
Purpose of the study
Treatment
Query!
Allocation to intervention
Non-randomised trial
Query!
Procedure for enrolling a subject and allocating the treatment (allocation concealment procedures)
Query!
Methods used to generate the sequence in which subjects will be randomised (sequence generation)
Query!
Masking / blinding
Open (masking not used)
Query!
Who is / are masked / blinded?
Query!
Query!
Query!
Query!
Intervention assignment
Parallel
Query!
Other design features
Query!
Phase
Phase 3
Query!
Type of endpoint/s
Safety/efficacy
Query!
Statistical methods / analysis
Query!
Recruitment
Recruitment status
Recruiting
Query!
Date of first participant enrolment
Anticipated
1/11/2004
Query!
Actual
Query!
Date of last participant enrolment
Anticipated
Query!
Actual
Query!
Date of last data collection
Anticipated
Query!
Actual
Query!
Sample size
Target
20
Query!
Accrual to date
Query!
Final
Query!
Recruitment in Australia
Recruitment state(s)
Query!
Funding & Sponsors
Funding source category [1]
226
0
Other
Query!
Name [1]
226
0
Institute for Neuromuscular Research
Query!
Address [1]
226
0
Query!
Country [1]
226
0
Australia
Query!
Primary sponsor type
Hospital
Query!
Name
The Children's Hospital at Westmead
Query!
Address
Query!
Country
Australia
Query!
Secondary sponsor category [1]
169
0
None
Query!
Name [1]
169
0
None
Query!
Address [1]
169
0
Query!
Country [1]
169
0
Query!
Ethics approval
Ethics application status
Approved
Query!
Summary
Brief summary
Trial of Deflazacort, a steroid which is not currently commercially available in Australia, for boys with DMD who have failed Prednisone trials
Query!
Trial website
Query!
Trial related presentations / publications
Query!
Public notes
Query!
Contacts
Principal investigator
Name
36152
0
Query!
Address
36152
0
Query!
Country
36152
0
Query!
Phone
36152
0
Query!
Fax
36152
0
Query!
Email
36152
0
Query!
Contact person for public queries
Name
9253
0
Sian Rudge
Query!
Address
9253
0
Clinical Sciences
The Children's Hospital at Westmead
Locked Bag 4001
Westmead NSW 2145
Query!
Country
9253
0
Australia
Query!
Phone
9253
0
+61 2 98451229
Query!
Fax
9253
0
+61 2 98451317
Query!
Email
9253
0
[email protected]
Query!
Contact person for scientific queries
Name
181
0
Sian Rudge
Query!
Address
181
0
Clinical Sciences
The Children's Hospital at Westmead
Locked Bag 4001
Westmead NSW 2145
Query!
Country
181
0
Australia
Query!
Phone
181
0
+61 2 98451229
Query!
Fax
181
0
+61 2 98451317
Query!
Email
181
0
[email protected]
Query!
No information has been provided regarding IPD availability
What supporting documents are/will be available?
No Supporting Document Provided
Results publications and other study-related documents
Documents added manually
No documents have been uploaded by study researchers.
Documents added automatically
No additional documents have been identified.
Download to PDF